Loading clinical trials...
Loading clinical trials...
Vibroacoustic pulmonary therapy in patients with COVID19 is believed to have a positive effect on oxygen status and a decrease in the duration of respiratory failure
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Astana Medical University
NCT07261787 · Neonates and Preterm Infants, Infant Respiratory Distress Syndrome, and more
NCT06501118 · Respiratory Failure, Acute Hypoxemic Respiratory Failure, and more
NCT07251790 · Respiratory Distress Syndrome, Newborn, Respiratory Distress Syndrome in Premature Infant
NCT06776783 · Respiratory Distress Syndrome, Pre-term Infants
NCT04565665 · COVID-19 Infection, COVID-19-Associated Acute Respiratory Distress Syndrome, and more
Mukatova Irina
Astana, Astana
Center of pulmonology Astana
Astana
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions